-
7 Catalysts For Eli Lilly Over The Next Year
Tuesday, October 10, 2017 - 10:33am | 479Credit Suisse in a note Monday listed seven catalysts for Eli Lilly and Co (NYSE: LLY) shares over the coming year even as it downgraded the shares of the company on the pretext that there are limited drivers of further upside after the stock's recent run, which lifted it by 13 percent since mid-...
-
Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive'
Wednesday, August 16, 2017 - 11:59am | 534Credit Suisse termed the market reaction to Bristol-Myers Squibb Co (NYSE: BMY)'s CM-214 data as overly pessimistic. The comment was based on the 3-percent pullback in the company's shares in after-hours trading Tuesday. However, at the time of writing, shares of Bristol-Myers Squibb were down 1....